02/09/2026
RESET-RA explores a fascinating new direction in rheumatoid arthritis treatment — using the nervous system to influence inflammation.
Instead of targeting a cytokine or immune cell with another drug, a small implanted device stimulates the vagus nerve for just 1 minute each day, engaging neuroimmune pathways involved in inflammatory regulation.
In this randomized, double-blind, sham-controlled trial of 242 patients with moderately-to-severely active RA, active vagus nerve stimulation produced a significantly higher ACR20 response at 3 months than sham stimulation (35.2% vs 24.2%).
The effect is modest, but the concept is important: the nervous system itself may become a therapeutic target in immune-mediated inflammatory disease.
Could bioelectronic medicine eventually become another option alongside DMARDs, biologics and targeted therapies?
RESET-RA | Nature Medicine | 2026
Neuroimmunology AutoimmuneDisease Inflammation RheumatologyResearch DrRamaniRheumatology